O
ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ · Healthcare · 1.4B
Closing price
$11.99
-0.33% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
-7.9×
Free cash flow yieldFCF yield
-10.8%
Return on equityROE
-33.7%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.